← Open Payments lookup

KOMPAL PARMAR: Open Payments

NPI 1710270988 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,649 in 149 payments from 23 companies in 2025. Trend: 2023 $1,786 · 2024 $1,715 · 2025 $3,649

Food & beverage: $3,649
CompanyPaymentsAmount
ABBVIE INC.17$397
MAYNE PHARMA COMMERCIAL LLC7$339
Novo Nordisk Inc15$330
GlaxoSmithKline, LLC.18$304
Verona Pharma, Inc.13$259
Amgen Inc.12$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$207
Axsome Therapeutics, Inc.10$195
Bayer Healthcare Pharmaceuticals Inc.5$179
AstraZeneca Pharmaceuticals LP3$160

Products named: Ohtuvayre, Wegovy, QULIPTA, CAPLYTA, Kerendia, Auvelity, AIRSUPRA, GEMTESA.

Industry payments across TX — which companies pay providers there.